A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...
A groundbreaking prostate treatment offering life-changing relief for men has reached Far North Queensland, transforming ...
“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.” As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...
Prostate cancer treatments lead to higher long-term complication rates, emphasizing the need for informed decision-making regarding treatment options and side effects. Prostatectomy patients ...
Despite medical advances and increased awareness campaigns, many men continue postponing essential prostate treatment. Health care providers identify several key factors contributing to these ...
Prostate involvement was first reported in IgG4-RD approximately 2 decades ago and comprises only 9.6% of cases. A male patient in his 7os presented with isolated prostatitis associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback